Log In Sign up
The largest database of trusted experimental protocols

Mir 152 3p mimics inhibitor

Manufactured by GenePharma
Visit Supplier
Sourced in China

MiR-152-3p mimics/inhibitor is a laboratory reagent used to modulate the expression of the miR-152-3p microRNA. It can be used to either increase or decrease the levels of this specific microRNA in experimental cell or tissue samples.

Automatically generated - may contain errors

Lab products found in correlation

Nc mimics inhibitor, by GenePharma (2 mentions) Lipofectamine 2000, by Thermo Fisher Scientific (2 mentions) Sh nc, by GenePharma (1 mentions) Pcdna3, by GenePharma (1 mentions)

Spelling variants of this product

MiR-152-3p mimic (9 citations) MiR-152 inhibitor (5 citations) MiR-152-3p inhibitor (4 citations) MiR-152 mimics (4 citations) MiR-mimics (3 citations) MiR-152-3p (2 citations)

2 protocols using mir 152 3p mimics inhibitor

1

Silencing and Overexpression of OIP5-AS1 and SLC7A5

Check if the same lab product or an alternative is used in the 5 most similar protocols
The short hairpin RNAs (shRNAs) against OIP5-AS1 were constructed by Genepharma (Shanghai, China) for gene silencing analysis, as well as its control, sh-NC. The pcDNA3.1/OIP5-AS1, pcDNA3.1/SLC7A5 and the control pcDNA3.1 vectors were commercially obtained from Ribobio (Guangzhou, China) to up-regulate target genes. Besides, the miR-152-3p mimics/inhibitor, as well as the corresponding negative control (NC mimics/inhibitor) were designed at Genepharma. Plasmids were transfected into EC cell for 48 h via Lipofectamine 2000 (Invitrogen).
Liang M., Wang H., Liu C., Lei T, & Min J. (2021). OIP5-AS1 contributes to the development in endometrial carcinoma cells by targeting miR-152-3p to up-regulate SLC7A5. Cancer Cell International, 21, 440.
+ Open protocol
+ Expand
2

Examining the Role of HCG18 and RAB14

Check if the same lab product or an alternative is used in the 5 most similar protocols
Short hairpin (sh) RNA targeting HCG18 (shHCG18; 5ʹ-UGAGCGGCUGUGCUAUACAUGUG-3ʹ), RAB14 (shRAB14; 5ʹ-GCAGUUCACAAGUAGUACUGG-3ʹ) with their negative control (shNC), miR-152-3p mimics/inhibitor with their negative controls (NC mimics/inhibitor), and pcDNA3.1/RAB14 with its negative control (pcDNA3.1) were synthesized by GenePharma (Shanghai, China). Cell transfection was performed using Lipofectamine 2000 (Invitrogen).
Yang Y., Gong P., Yao D., Xue D, & He X. (2021). LncRNA HCG18 Promotes Clear Cell Renal Cell Carcinoma Progression by Targeting miR-152-3p to Upregulate RAB14. Cancer Management and Research, 13, 2287-2294.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!